Brandywine Global Investment Management, LLC Vanda Pharmaceuticals Inc. Transaction History
Brandywine Global Investment Management, LLC
- $13.7 Billion
- Q2 2025
A detailed history of Brandywine Global Investment Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 39,390 shares of VNDA stock, worth $172,528. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,390
Previous 39,390
-0.0%
Holding current value
$172,528
Previous $180,000
2.78%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VNDA
# of Institutions
152Shares Held
43.9MCall Options Held
13.8KPut Options Held
1.01M-
Black Rock Inc. New York, NY8.14MShares$35.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$15.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.45MShares$15.1 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.12MShares$13.7 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$11.2 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $248M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...